Atogepant API is a selective calcitonin gene-related peptide (CGRP) receptor antagonist used for the preventive treatment of migraine. It works by blocking CGRP-mediated vasodilation and pain signaling pathways. Atogepant API is produced under GMP standards and is suitable for oral tablet formulations.

Atogepant API is manufactured and supplied by ASTANDARDS | Artis Biotech, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.